We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Nomura Research Institute, Nissan Motors and Sumitomo
Read MoreHide Full Article
For Immediate Release
Chicago, IL – December 28, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Nomura Research Institute, Ltd. (NRILY - Free Report) , Nissan Motors Co., Ltd. (NSANY - Free Report) and Sumitomo Corporation (SSUMY - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Goodbye 2021: Global Week Ahead
This is the final Global Week Ahead for 2021.
2022 enters the stage at the end of the week.
Every global news service task, at the moment? Carefully updating traders about the latest signs on the rapidly-spreading Omicron COVID variant.
According to Reuters --
(1) Omicron Variant News Dominates
How much could this mutated COVID virus impact the U.S. and global economy and earnings as stock markets head into what has historically been a strong time of year for equities?
Overall, the S&P 500 is slightly ahead since Nov. 24th, prior to news of the variant hitting.
The S&P 500 marked a record-high close on Thursday Dec. 23rd at 4,726, as encouraging developments gave investors more ease about the impact.
The Omicron variant is causing infections to double in 1.5 to 3 days, according to the World Health Organization (WHO). The variant now accounts for 73% of all new U.S. cases, up from less than 1% at the beginning of the month.
Still, questions about Omicron's virulence have made investors less pessimistic than the original reaction. The S&P 500 closed down -2.3% on Nov. 26th after the variant was discovered, on fears of fresh economic lockdowns.
A South African study offered hope about the severity of Omicron and the trend of COVID-19 infections on Wednesday, Dec. 22nd.
Shares of vaccine makers slumped in December as investors expect the Omicron variant's impact to be limited based on recent data.
(2) A Santa Claus Rally Already Showed Up
Historically, U.S. stocks have risen during the last five trading days of December and the first two days of January — in 56 out of 75 years since 1945, according to data from CFRA Research.
This year, the time period starts today, Dec. 27th.
The average Santa Claus rally has boosted the S&P 500 by +1.3% since 1969, according to the Stock Trader's Almanac.
It is unclear to what extent Wall Street analysts expect Omicron to affect earnings and the economy. Estimated 2022 S&P 500 earnings growth was at +8.3% as of Friday, Dec. 24th, compared with +8.0% at the start of December, according to Refinitiv data.
Goldman Sachs cut its estimate for U.S. GDP growth to +3.8% from +4.2% due to the uncertainty of the impact of the Omicron wave.
(3) Any Good News from Senator Manchin in the Offing?
While there will likely be some economic impact from Omicron, U.S. consumer spending will likely remain strong, says Cliff Hodge, CIO for Cornerstone Wealth.
He is focused on any signs that Senator Joe Manchin (D-WV) could reach an agreement to support President Joe Biden's signature $1.75T Build Back Better climate and social spending bill.
Manchin, who would provide one of the key votes to pass the bill in a divided Senate, said on Sunday Dec. 19th that he could not support the bill in its current form. Senate Majority Leader Chuck Schumer (D-NY) said that the Senate will vote on the bill in early January.
"We need a little bit of good news — whether on the Manchin front or Omicron — to get a rally going,” Hodge said. "We are fully invested and anticipate a little bit of a relief rally into January.”
Top Zacks #1 Rank (STRONG BUY) Stocks
Here are three Japanese large-cap stocks on our current #1 list.
(1) Nomura Research Institute : This is categorized as a “tech services” company now, though financial IT services may be more accurate.
Shares trade at $43. The market cap is $26.3B. I see a Zacks Value score of F, a Zacks Growth score of B and a Zacks Momentum score of A. The F12M P/E ratio is 38.1.
(2) Nissan Motors : This is the auto maker.
Shares trade at a paltry $9.80 each. The market cap is $20.7B. I see a Zacks Value score of A, a Zacks Growth score of B and a Zacks Momentum score of B. The F12M P/E valuation ratio is 12.0.
(3) Sumitomo : Diversified operations is what this company does.
I see a paltry $14.70 share price. The market cap is $18.4B. I see a Zacks Value score of A, a Zacks Growth score of D and a Zacks Momentum score of B. I saw a very low F12M P/E valuation ratio of 5.7.
Will traders and investors care about Japanese stocks in 2022? They mostly ignored them in 2021.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Nomura Research Institute, Nissan Motors and Sumitomo
For Immediate Release
Chicago, IL – December 28, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Nomura Research Institute, Ltd. (NRILY - Free Report) , Nissan Motors Co., Ltd. (NSANY - Free Report) and Sumitomo Corporation (SSUMY - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Goodbye 2021: Global Week Ahead
This is the final Global Week Ahead for 2021.
2022 enters the stage at the end of the week.
Every global news service task, at the moment? Carefully updating traders about the latest signs on the rapidly-spreading Omicron COVID variant.
According to Reuters --
(1) Omicron Variant News Dominates
How much could this mutated COVID virus impact the U.S. and global economy and earnings as stock markets head into what has historically been a strong time of year for equities?
Overall, the S&P 500 is slightly ahead since Nov. 24th, prior to news of the variant hitting.
The S&P 500 marked a record-high close on Thursday Dec. 23rd at 4,726, as encouraging developments gave investors more ease about the impact.
The Omicron variant is causing infections to double in 1.5 to 3 days, according to the World Health Organization (WHO). The variant now accounts for 73% of all new U.S. cases, up from less than 1% at the beginning of the month.
Still, questions about Omicron's virulence have made investors less pessimistic than the original reaction. The S&P 500 closed down -2.3% on Nov. 26th after the variant was discovered, on fears of fresh economic lockdowns.
A South African study offered hope about the severity of Omicron and the trend of COVID-19 infections on Wednesday, Dec. 22nd.
Shares of vaccine makers slumped in December as investors expect the Omicron variant's impact to be limited based on recent data.
(2) A Santa Claus Rally Already Showed Up
Historically, U.S. stocks have risen during the last five trading days of December and the first two days of January — in 56 out of 75 years since 1945, according to data from CFRA Research.
This year, the time period starts today, Dec. 27th.
The average Santa Claus rally has boosted the S&P 500 by +1.3% since 1969, according to the Stock Trader's Almanac.
It is unclear to what extent Wall Street analysts expect Omicron to affect earnings and the economy. Estimated 2022 S&P 500 earnings growth was at +8.3% as of Friday, Dec. 24th, compared with +8.0% at the start of December, according to Refinitiv data.
Goldman Sachs cut its estimate for U.S. GDP growth to +3.8% from +4.2% due to the uncertainty of the impact of the Omicron wave.
(3) Any Good News from Senator Manchin in the Offing?
While there will likely be some economic impact from Omicron, U.S. consumer spending will likely remain strong, says Cliff Hodge, CIO for Cornerstone Wealth.
He is focused on any signs that Senator Joe Manchin (D-WV) could reach an agreement to support President Joe Biden's signature $1.75T Build Back Better climate and social spending bill.
Manchin, who would provide one of the key votes to pass the bill in a divided Senate, said on Sunday Dec. 19th that he could not support the bill in its current form. Senate Majority Leader Chuck Schumer (D-NY) said that the Senate will vote on the bill in early January.
"We need a little bit of good news — whether on the Manchin front or Omicron — to get a rally going,” Hodge said. "We are fully invested and anticipate a little bit of a relief rally into January.”
Top Zacks #1 Rank (STRONG BUY) Stocks
Here are three Japanese large-cap stocks on our current #1 list.
(1) Nomura Research Institute : This is categorized as a “tech services” company now, though financial IT services may be more accurate.
Shares trade at $43. The market cap is $26.3B. I see a Zacks Value score of F, a Zacks Growth score of B and a Zacks Momentum score of A. The F12M P/E ratio is 38.1.
(2) Nissan Motors : This is the auto maker.
Shares trade at a paltry $9.80 each. The market cap is $20.7B. I see a Zacks Value score of A, a Zacks Growth score of B and a Zacks Momentum score of B. The F12M P/E valuation ratio is 12.0.
(3) Sumitomo : Diversified operations is what this company does.
I see a paltry $14.70 share price. The market cap is $18.4B. I see a Zacks Value score of A, a Zacks Growth score of D and a Zacks Momentum score of B. I saw a very low F12M P/E valuation ratio of 5.7.
Will traders and investors care about Japanese stocks in 2022? They mostly ignored them in 2021.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.